BTIG Initiates Coverage On BrightSpring Health with Buy Rating, Announces Price Target of $15
Portfolio Pulse from Benzinga Newsdesk
BTIG initiates coverage on BrightSpring Health (NASDAQ:BTSG) with a Buy rating and sets a price target of $15.
June 21, 2024 | 10:21 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
BTIG analyst David Larsen has initiated coverage on BrightSpring Health with a Buy rating and a price target of $15.
The initiation of coverage with a Buy rating and a specific price target of $15 by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100